Mengke Pharmaceutical announced that from January 28, 2026 to April 27, 2026, MicurXLimited will hold 70.68% of the company's shares; it plans to reduce its holdings by no more than 6.5561 million shares and no more than 13.1121 million shares through centralized bidding, totaling no more than 19.682 million shares, accounting for 3% of the company's total share capital, and the reduced holdings price will not be lower than the company's initial public offering price.

Mengke Pharmaceutical announced that from January 28, 2026 to April 27, 2026, MicurXLimited will hold 70.68% of the company's shares; it plans to reduce its holdings by no more than 6.5561 million shares and no more than 13.1121 million shares through centralized bidding, totaling no more than 19.682 million shares, accounting for 3% of the company's total share capital, and the reduced holdings price will not be lower than the company's initial public offering price.